Results

Total Results: over 10,000 records

Showing results for "described".

  1. psnet.ahrq.gov/issue/non-health-care-facility-medication-errors-resulting-serious-medical-outcomes
    June 14, 2017 - Medication errors that occur in health care settings have been well described, but less is known about … A previous WebM&M commentary described a near miss in which a patient almost administered the wrong
  2. psnet.ahrq.gov/issue/contributing-factors-identified-hospital-incident-report-narratives
    January 02, 2017 - to determine at least one underlying factor in most reports, but found that incidents often were not described … A prior study described an intervention to improve the number and quality of voluntarily filed incident
  3. psnet.ahrq.gov/issue/disclosure-apology-and-offer-programs-stakeholders-views-barriers-and-strategies-broad
    December 19, 2018 - apology, and offer strategy for medical errors, with the University of Michigan program being the best described … However, none of the barriers described were felt to be insurmountable. Dr.
  4. www.ahrq.gov/funding/priorities-contacts/index.html
    July 01, 2021 - AHRQ priorities are described.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
    September 08, 2011 - o Were inclusion/exclusion criteria clearly described? … o Were baseline prognostic characteristics clearly described and groups shown to be comparable? … o Were selection criteria clearly described? … o Was the execution of the reference standard described in sufficient detail to permit replication … The strength of the overall body of evidence will be rated by using the system described in the
  6. www.ahrq.gov/sites/default/files/wysiwyg/nhguide/5_TK3_P3T4-Training_Slides_for_Prescribing_Clinicians_Phase_3.ppt
    May 01, 2014 - Which of the following do you think is/are the most appropriate antibiotic(s) for the above described … Which of the following do you think is/are the most appropriate antibiotic(s) for the above described … Which of the following do you think is/are the most appropriate antibiotic(s) for the above described … Which of the following do you think is/are the most appropriate antibiotic(s) for the above described
  7. www.ahrq.gov/teamstepps-program/curriculum/intro/teach/mini.html
    June 01, 2023 - groundwork for subsequent short trainings on particular tools, then choose to use the introductory materials described
  8. www.ahrq.gov/teamstepps-program/resources/additional/cus-sbar-rural-clinic.html
    August 01, 2023 - www.youtube-nocookie.com/embed/RGECauNaBS4 TeamSTEPPS: Using CUS and SBAR in Rural Community Clinic (audio-described
  9. digital.ahrq.gov/sites/default/files/docs/lesson/09-0023-ef-bcma.pdf
    December 01, 2008 - With best-of-breed systems, many grantees described the difficulty and cost of building interfaces … Respondents described this as an “intertwining” process. … Grantees described the value of setting realistic expectations: “We had heard from other hospitals … One project described the need to dedicate an entire FTE to these tasks alone. … The BCMA and eMAR projects described in this report have illuminated a number of important lessons
  10. www.ahrq.gov/ncepcr/reports/2024-annual-report/recent-grants-systems.html
    May 01, 2024 - An additional 11 primary care grants had some focus on healthcare systems or infrastructure and are described … Healthcare Financing and Payment Reform Six studies focus on healthcare financing and payment reform, as described … Care Coordination Across Settings Seven studies focus on care coordination across settings, as described … The data resources are described below with links to additional information or to the specific material … As described on the MEPS webpage: "MEPS currently has two major components: the Household Component
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
    September 01, 2011 - This is now described in the text. … This is now described. … However, while anakinra is correctly described as a an IL-1 receptor antagonist, canakinumab is described … This is described in the methods. … As described, that was an editing error.
  12. www.ahrq.gov/cahps/surveys-guidance/maternal-health/index.html
    March 01, 2025 - Findings from Focus Groups Patients described care from two sets of teams: (1) labor and delivery, and … Participants often described these two sets of teams as having different skills, observing that postpartum
  13. www.ahrq.gov/healthsystemsresearch/hspc-research-study/study-methods.html
    June 01, 2020 - Agency representatives in the study’s Federal Advisory Group, described above, as well as points of contact … As described below, TEP members were recruited first, then participants for the stakeholder interviews … Interview Selection and Recruitment Individuals from the sampling pool described above who did not … As described above, an individual project could be determined to meet all or none of these three in-scope … As described below, we drew on these and similar efforts to automate our analysis of the roughly 90,000
  14. psnet.ahrq.gov/cme-video
    August 11, 2025 - Audio-Described Version  (1 minute 24 seconds)
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-269-respectful-maternity-care-disposition-comments.pdf
    January 02, 2024 - This review aimed to define and measure RMC and the absence of RMC, described as disrespect or abuse … Additional details are described in the full report. … How the authors arrived at this definition is not described well. Is this a consensus definition? … We have described our approach in the Discussion section 4.4. … Additional limitations of the research also described in the discussion.
  16. digital.ahrq.gov/sites/default/files/docs/resource/C4_Patient_Informed_Consent_Form.pdf
    September 30, 2008 - as principal investigator and/or such assistant as may be selected by him to perform the procedure described … (collectively referred to as the “Third Parties”) for use and disclosure by such Third Parties as described … three (3_) years, the Principal Investigator and the Third Parties will continue using your PHI as described … signing this consent form, you authorize the use and disclosure of health information about you as described … You freely consent to participate in this study under the conditions described in this document.
  17. psnet.ahrq.gov/innovations-video
    August 09, 2025 - Audio-Described Version  (1 minute, 8 seconds)
  18. psnet.ahrq.gov/shared-libraries
    May 19, 2025 - Login or Register to Get Started Audio-Described Version (2 minutes, 35 seconds)
  19. psnet.ahrq.gov/submit-case
    August 10, 2025 - Submit Your Case   Audio-Described Version  (1 minute, 39 seconds)
  20. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0209-technical-specs.pdf
    June 02, 2025 - The adjusted results of the outcome rates using all of these variables are described as “Adjusted Model